SCHEMBL2401248

SCHEMBL2401248

CCc1ccc(-c2nc3c(o2)C(=O)C(N2CCC2N(C)C2CCN2C2=CC(=O)c4nc(-c5ccc(CC)cc5)oc4C2=O)=CC3=O)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 4/20 0.35
▸ NOTUM Q6P988 1/20 0.33
▸ MAPT P10636 6/20 0.33
▸ POLB P06746 4/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ TDP2 O95551 2/20 0.32
▸ USP2 O75604 3/20 0.32
▸ LMNA P02545 3/20 0.32
▸ CDC25A P30304 1/20 0.32
▸ CDC25B P30305 1/20 0.32
▸ CDC25C P30307 1/20 0.32
▸ USP1 O94782 2/20 0.31
▸ USP19 O94966 2/20 0.31
▸ UCHL3 P15374 1/20 0.31
▸ WDR48 Q8TAF3 1/20 0.31
▸ KMT2A Q03164 3/20 0.31
▸ SMN1; SMN2 Q16637 3/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ MAPK1 P28482 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2398532 0.88 MEN1 (0.33) MAPTTP53CDC25ACDC25BCDC25C
SCHEMBL2404414 0.88 USP1 (0.44) MAPTALDH1A1CDC25ACDC25BCDC25C
SCHEMBL2403259 0.81 TP53 (0.36) NOTUMMAPTTP53USP2KMT2A
SCHEMBL2401601 0.77 CDC25A (0.55) ALDH1A1USP2CDC25ACDC25BCDC25C
SCHEMBL2398455 0.71 NOTUM (0.41) NOTUMMAPTALDH1A1TP53TDP2
SCHEMBL1917840 0.71 MEN1 (0.45) NPSR1MAPTPOLBALDH1A1TP53
SCHEMBL1917683 0.70 CDC25A (0.61) NOTUMMAPTPOLBALDH1A1TP53
SCHEMBL2401246 0.69 CDC25A (0.49) NOTUMMAPTPOLBALDH1A1TP53
SCHEMBL1919229 0.65 MEN1 (0.45) NPSR1MAPTPOLBALDH1A1TP53
SCHEMBL1917209 0.64 CDC25A (0.51) NOTUMMAPTPOLBALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275624-A1 INHIBITORS OF CDC PHOSPHATASES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-11-05 — — US claimed
EP-1831209-B1 CDC25 PHOSPHATASE INHIBITORS IPSEN PHARMA (FR) 2009-08-12 — — EP claimed
US-8017637-B2 Inhibitors of cdc phosphatases IPSEN PHARMA S.A.S. (FR) 2011-09-13 — — US disclosed
US-20090275624-A1 INHIBITORS OF CDC PHOSPHATASES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2009-11-05 — — US disclosed
EP-1831209-B1 CDC25 PHOSPHATASE INHIBITORS IPSEN PHARMA (FR) 2009-08-12 — — EP disclosed
EP-1831209-A2 CDC25 PHOSPHATASE INHIBITORS Société de Conseils de Recherches et d'Applications Scientifiques SAS (S.C.R.A.S) (FR) 2007-09-12 — — EP disclosed
WO-2006067311-A2 CDC25 PHOSPHATASE INHIBITORS SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) SAS (FR) 2006-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275624-A1 INHIBITORS OF CDC PHOSPHATASES CDC25C, CDC25A, CDC25B NPSR1 4562/4885NOTUM 2577/4885MAPT 4084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback